UroGen Pharma Announces Pricing Of Public Offering Of Shares And Pre-Funded Warrants
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – UroGen Pharma Ltd. (URGN) announced the pricing of an underwritten public offering of 5 million ordinary shares at a price to the public of $17.50 per ordinary share, and, to certain investors in lieu of issuing ordinary shares, pre-funded warrants to purchase 1.14 mi
:max_bytes(150000):strip_icc():format(jpeg)/Sophisticated-Index-Fund-Investing-56a092ca5f9b58eba4b1aba2.jpg "The 3 Largest Global Ex-U.S. ETFs")
:max_bytes(150000):strip_icc():format(jpeg)/LeadImage-first-time-home-buyer-v12-58a9c0ab45424243987ac60002d74587.png "How To Buy a House: A Step-by-Step Guide")
:max_bytes(150000):strip_icc():format(jpeg)/Tips-For-NegotiatingClosing-v1-5c53a7c79cd645a4babd5c68c636cafa.png "10 Tips for Negotiating Closing Costs")
:max_bytes(150000):strip_icc():format(jpeg)/TipsforUsingAIToBuyaHome-v1-c5ca80ec76b841ddaa0e436c8bd4bc26.png "Tips for Using AI To Buy a Home")
:max_bytes(150000):strip_icc():format(jpeg)/HowToBuildYourHomebuyingTeam-v1-3ef5bf9df3dd4cccab7bc9be63a263e0.png "How To Build Your Homebuying Team")
